Glumin XR 500mg extended-release tablets

Ferron Par Pharmaceuticals

Ingredients in every extended-release tablet

Metformin HCL 500 mg

Each package contains

3 blisters of 10 extended-release tablets

Other details

Dosage form:Tablet; coated; extended-release
Flavour: None

W.H.O. classification

ATC Level 1: A - Alimentary tract and metabolism
ATC Level 2: A10 - Drugs Used in Diabetes
ATC Level 3: A10B - Blood Glucose Lowering Drugs; excl. Insulins

Warnings

Pregnancy

NOT SAFEThis item is not safe for use during pregnancy.

Lactation

NOT SAFEThis item is not safe for use during lactation.

Alcohol

NOT SAFEThis item should not be used with alcohol.

Machinery

CAUTIONThis item may not be safe for use while operating heavy machinery. Use with caution.

Available in

Indonesia
Myanmar
Cambodia

Dosage information

17 YEARS OLD AND ABOVE
Glumin XR® should generally be given once daily with the evening meal and should be started at a low dose, with gradual dose escalation. Subsequent dosage should be adjusted according to the patient’s therapeutic response, using the lowest possible effective dosage. Glumin XR® must be swallowed whole and never crushed or chewed.
In Adults, the usual starting dose of Glumin XR® is 500 mg once daily with the evening meal. Maximum recommended daily dose in Adults is 2,000 mg.
Dosage increases should be made in increments of 500 mg weekly, up to a maximum of 2,000 mg once daily with the evening meal. If glycemic control is not achieved on Glumin XR® 2,000 mg once daily, a trial of Glumin XR® 1,000 mg twice daily should be considered.
Safety and effectiveness of Glumin XR® in pediatric patients have not been established. Glumin XR® is not recommended in pediatric patients below the age of 17 years.

0 TO 17 YEARS OLD
Safety and effectiveness of Glumin XR® in pediatric patients have not been established. Glumin XR® is not recommended in pediatric patients below the age of 17 years.

Indication

As mono– or combined therapy with sulphonylurea in patients with Non-insulin-dependent diabetes mellitus (type 2 diabetes) especially if overweight and whose blood glucose level cannot be controlled by diet alone.
As an adjuvant therapy in insulin-dependent diabetic patients with hardly controlled symptoms.

Disclaimer

The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for informational purposes only. This tool may not cover all possible drug interactions or all warnings or alerts. Please check with a physician if you have health questions or concerns about interactions or go to the appropriate government authority for a comprehensive list of medical warnings. Although we attempt to provide accurate and up-to-date information, no guarantee is made to that effect.

All of the content present on this website, including written text, photographs, videos, graphics, and other resources we might include (these will fall under the collective term of “website”), is meant to educate and should not be perceived as a substitution for professional medical advice, diagnosis or treatment. You should not resort to the website information to arrive at a diagnosis or treatment solution for your health problems or various medical conditions. It does not replace medical care, provided by a medical specialist. In the situation, you have specific symptoms and you might suspect that you are suffering from a medical problem, it is for the best to consult your physician.